pharma news

News

GSK to quit Stevenage for new R&D site in Cambridge

In a major shake-up of its UK operations, GSK is building a brand new R&D centre in Cambridge and transfer operations there from its Stevenage campus.

News

HIV resurgence looming as international aid declines

More than 3m people worldwide could be infected with HIV by the end of the decade following a steep fall in international aid funding, says UNAIDS.

News

Severino takes the helm at Sarepta after turbulent spell

Around five months after long-serving CEO Doug Ingram said he was stepping down, Sarepta has named industry veteran Michael Severino to replace him.

News

IPO in wooden blocks on table with green foliage blurred in background

Scribe raises $155m in IPO, as Apnimed pitches for $150m

Gene-editing specialist Scribe becomes the 14th biotech to list on the Nasdaq this year, as sleep apnoea drug developer Apnimed prices its listing.

News

Is J&J approaching the end of its talc litigation hangover?

Johnson & Johnson has made a $5.5bn bid to finally bring more than 15 years of litigation over the safety of its talcum powder products to a close.

News

J&J's oral IL-23 drug backed for psoriasis in EU

J&J's oral psoriasis drug Icotyde heads up the list of new therapies recommended for EU approval at the CHMP's July meeting.

GSK to quit Stevenage for new R&D site in Cambridge

HIV resurgence looming as international aid declines

Severino takes the helm at Sarepta after turbulent spell

Scribe raises $155m in IPO, as Apnimed pitches for $150m

Is J&J approaching the end of its talc litigation hangover?

J&J's oral IL-23 drug backed for psoriasis in EU

Pharma leaders urge Europe to halt 'slow agony' of decline

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks